ロード中...
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
Members of the PI3K/Akt/mTor signaling cascade are among the most frequently altered proteins in cancer, yet the therapeutic application of pharmacological inhibitors of this signaling network, either as monotherapy or in combination therapy (CT) has so far not been particularly successful. In this...
保存先:
| 出版年: | Mol Cell Ther |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4452069/ https://ncbi.nlm.nih.gov/pubmed/26056598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2052-8426-2-32 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|